Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.

Similar Items

• A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses
  od: Katz-Levy, Yael, i dr.
  Izdano: (1997)
• Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice
  od: Paas-Rozner, Miri, i dr.
  Izdano: (2000)
• Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.
  od: Katz-Levy, Y, i dr.
  Izdano: (1993)
• The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes
  od: Paas-Rozner, Miri, i dr.
  Izdano: (2001)
• Direct binding of a myasthenia gravis related epitope to MHC class II molecules on living murine antigen-presenting cells.
  od: Mozes, E, i dr.
  Izdano: (1989)